Is PACS or AGL more profitable?

PACS Group has a net margin of 4.49% compared to Agilon Health's net margin of -6.09%. PACS Group's return on equity of 26.47% beat Agilon Health's return on equity. Company Net Margins Return on Equity Return on Assets PACS Group 4.49% 26.47% 4.36% Agilon Health -6.09% -146.03% -24.55%

Agilon Health (AGL) Competitors

$112.79 -1.01 (-0.89%)

Closing price 06/18/2026 03:59 PM Eastern

Extended Trading

$113.87 +1.08 (+0.96%)

As of 06/18/2026 07:03 PM Eastern

Compare

AGL vs. HIMS, PACS, CAI, BLLN, and SHC

Should you buy Agilon Health stock or one of its competitors? MarketBeat compares Agilon Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Agilon Health include Hims & Hers Health (HIMS), PACS Group (PACS), Caris Life Sciences (CAI), Billiontoone (BLLN), and Sotera Health (SHC). These companies are all part of the "healthcare" industry.

How does Agilon Health compare to Hims & Hers Health?

Agilon Health (NYSE:AGL) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, earnings, dividends and analyst recommendations.

63.5% of Hims & Hers Health shares are owned by institutional investors. 2.3% of Agilon Health shares are owned by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Agilon Health has a beta of 3, suggesting that its stock price is 200% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.37, suggesting that its stock price is 137% more volatile than the broader market.

Agilon Health presently has a consensus price target of $58.73, indicating a potential downside of 47.93%. Hims & Hers Health has a consensus price target of $29.37, indicating a potential downside of 17.14%. Given Hims & Hers Health's higher probable upside, analysts clearly believe Hims & Hers Health is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilon Health	2 Sell rating(s)	8 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.20
Hims & Hers Health	3 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.06

In the previous week, Hims & Hers Health had 23 more articles in the media than Agilon Health. MarketBeat recorded 23 mentions for Hims & Hers Health and 0 mentions for Agilon Health. Hims & Hers Health's average media sentiment score of 0.76 beat Agilon Health's score of 0.00 indicating that Hims & Hers Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Agilon Health	Neutral
Hims & Hers Health	Positive

Hims & Hers Health has a net margin of -0.56% compared to Agilon Health's net margin of -6.09%. Hims & Hers Health's return on equity of 6.10% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilon Health	-6.09%	-146.03%	-24.55%
Hims & Hers Health	-0.56%	6.10%	1.52%

Hims & Hers Health has lower revenue, but higher earnings than Agilon Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilon Health	$5.93B	0.32	-$391.35M	-$21.56	N/A
Hims & Hers Health	$2.35B	3.49	$128.37M	-$0.09	N/A

Summary

Hims & Hers Health beats Agilon Health on 11 of the 16 factors compared between the two stocks.

How does Agilon Health compare to PACS Group?

PACS Group (NYSE:PACS) and Agilon Health (NYSE:AGL) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, institutional ownership, risk, profitability and earnings.

PACS Group has a net margin of 4.49% compared to Agilon Health's net margin of -6.09%. PACS Group's return on equity of 26.47% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PACS Group	4.49%	26.47%	4.36%
Agilon Health	-6.09%	-146.03%	-24.55%

PACS Group has higher earnings, but lower revenue than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PACS Group	$5.29B	1.10	$191.54M	$1.56	23.51
Agilon Health	$5.93B	0.32	-$391.35M	-$21.56	N/A

PACS Group currently has a consensus price target of $48.00, indicating a potential upside of 30.88%. Agilon Health has a consensus price target of $58.73, indicating a potential downside of 47.93%. Given PACS Group's stronger consensus rating and higher probable upside, analysts clearly believe PACS Group is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
Agilon Health	2 Sell rating(s)	8 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.20

In the previous week, PACS Group had 7 more articles in the media than Agilon Health. MarketBeat recorded 7 mentions for PACS Group and 0 mentions for Agilon Health. Agilon Health's average media sentiment score of 0.00 beat PACS Group's score of -0.12 indicating that Agilon Health is being referred to more favorably in the news media.

Company	Overall Sentiment
PACS Group	Neutral
Agilon Health	Neutral

Summary

PACS Group beats Agilon Health on 10 of the 12 factors compared between the two stocks.

How does Agilon Health compare to Caris Life Sciences?

Caris Life Sciences (NASDAQ:CAI) and Agilon Health (NYSE:AGL) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and media sentiment.

In the previous week, Caris Life Sciences had 5 more articles in the media than Agilon Health. MarketBeat recorded 5 mentions for Caris Life Sciences and 0 mentions for Agilon Health. Caris Life Sciences' average media sentiment score of 0.31 beat Agilon Health's score of 0.00 indicating that Caris Life Sciences is being referred to more favorably in the media.

Company	Overall Sentiment
Caris Life Sciences	Neutral
Agilon Health	Neutral

Caris Life Sciences has a net margin of 3.75% compared to Agilon Health's net margin of -6.09%. Caris Life Sciences' return on equity of 98.28% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Caris Life Sciences	3.75%	98.28%	48.87%
Agilon Health	-6.09%	-146.03%	-24.55%

Caris Life Sciences currently has a consensus price target of $27.56, suggesting a potential upside of 49.19%. Agilon Health has a consensus price target of $58.73, suggesting a potential downside of 47.93%. Given Caris Life Sciences' stronger consensus rating and higher possible upside, research analysts plainly believe Caris Life Sciences is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45
Agilon Health	2 Sell rating(s)	8 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.20

Caris Life Sciences has higher earnings, but lower revenue than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Caris Life Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Caris Life Sciences	$812.03M	6.43	-$68.09M	-$7.61	N/A
Agilon Health	$5.93B	0.32	-$391.35M	-$21.56	N/A

Summary

Caris Life Sciences beats Agilon Health on 12 of the 13 factors compared between the two stocks.

How does Agilon Health compare to Billiontoone?

Agilon Health (NYSE:AGL) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations, institutional ownership and media sentiment.

In the previous week, Billiontoone had 5 more articles in the media than Agilon Health. MarketBeat recorded 5 mentions for Billiontoone and 0 mentions for Agilon Health. Agilon Health's average media sentiment score of 0.00 beat Billiontoone's score of -0.44 indicating that Agilon Health is being referred to more favorably in the media.

Company	Overall Sentiment
Agilon Health	Neutral
Billiontoone	Neutral

Billiontoone has a net margin of 0.00% compared to Agilon Health's net margin of -6.09%. Billiontoone's return on equity of 0.00% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilon Health	-6.09%	-146.03%	-24.55%
Billiontoone	N/A	N/A	N/A

Billiontoone has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilon Health	$5.93B	0.32	-$391.35M	-$21.56	N/A
Billiontoone	$305.11M	15.85	$7.45M	$0.55	191.18

Agilon Health currently has a consensus price target of $58.73, indicating a potential downside of 47.93%. Billiontoone has a consensus price target of $125.29, indicating a potential upside of 19.15%. Given Billiontoone's stronger consensus rating and higher possible upside, analysts plainly believe Billiontoone is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilon Health	2 Sell rating(s)	8 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.20
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Billiontoone beats Agilon Health on 11 of the 13 factors compared between the two stocks.

How does Agilon Health compare to Sotera Health?

Agilon Health (NYSE:AGL) and Sotera Health (NASDAQ:SHC) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, dividends, institutional ownership, media sentiment, risk and profitability.

Agilon Health has a beta of 3, meaning that its share price is 200% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.79, meaning that its share price is 79% more volatile than the broader market.

In the previous week, Sotera Health had 1 more articles in the media than Agilon Health. MarketBeat recorded 1 mentions for Sotera Health and 0 mentions for Agilon Health. Agilon Health's average media sentiment score of 0.00 equaled Sotera Health'saverage media sentiment score.

Company	Overall Sentiment
Agilon Health	Neutral
Sotera Health	Neutral

Agilon Health presently has a consensus price target of $58.73, indicating a potential downside of 47.93%. Sotera Health has a consensus price target of $20.29, indicating a potential upside of 28.23%. Given Sotera Health's stronger consensus rating and higher possible upside, analysts clearly believe Sotera Health is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilon Health	2 Sell rating(s)	8 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.20
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

Sotera Health has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilon Health	$5.93B	0.32	-$391.35M	-$21.56	N/A
Sotera Health	$1.16B	3.88	$77.94M	$0.41	38.59

Sotera Health has a net margin of 9.91% compared to Agilon Health's net margin of -6.09%. Sotera Health's return on equity of 39.73% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilon Health	-6.09%	-146.03%	-24.55%
Sotera Health	9.91%	39.73%	7.05%

91.0% of Sotera Health shares are owned by institutional investors. 2.3% of Agilon Health shares are owned by insiders. Comparatively, 15.4% of Sotera Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Sotera Health beats Agilon Health on 13 of the 15 factors compared between the two stocks.

Get Agilon Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AGL vs. The Competition

Export

Metric	Agilon Health	Medical Services Industry	Medical Sector	NYSE Exchange
Market Cap	$1.90B	$8.76B	$6.65B	$23.21B
Dividend Yield	N/A	1.73%	2.68%	4.06%
P/E Ratio	-5.23	24.73	24.75	31.61
Price / Sales	0.32	16.61	529.30	22.84
Price / Cash	N/A	13.96	27.92	18.67
Price / Book	14.76	5.64	10.81	4.69
Net Income	-$391.35M	$179.69M	$3.57B	$1.08B
7 Day Performance	-0.12%	1.96%	0.72%	-0.82%
1 Month Performance	40.61%	2.99%	0.41%	1.07%
1 Year Performance	113.31%	6.36%	29.34%	25.02%

Agilon Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AGL Agilon Health	1.2747 of 5 stars	$112.79 -0.9%	$58.73 -47.9%	+113.3%	$1.90B	$5.93B	N/A	1,076	Gap Down
HIMS Hims & Hers Health	3.0178 of 5 stars	$30.10 +12.2%	$28.70 -4.6%	-45.0%	$6.21B	$2.35B	N/A	2,442	Analyst Forecast Insider Trade Gap Down
PACS PACS Group	3.796 of 5 stars	$36.23 -0.2%	$48.00 +32.5%	+176.8%	$5.74B	$5.29B	23.22	47,455	News Coverage Insider Trade
CAI Caris Life Sciences	4.3744 of 5 stars	$18.18 +1.2%	$27.56 +51.6%	N/A	$5.08B	$812.03M	N/A	1,846
BLLN Billiontoone	3.288 of 5 stars	$103.95 +2.8%	$125.29 +20.5%	N/A	$4.65B	$305.11M	189.00	620	News Coverage Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:AGL) was last updated on 6/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Agilon Health (AGL) Competitors

AGL vs. HIMS, PACS, CAI, BLLN, and SHC

How does Agilon Health compare to Hims & Hers Health?

Summary

How does Agilon Health compare to PACS Group?

Summary

How does Agilon Health compare to Caris Life Sciences?

Summary

How does Agilon Health compare to Billiontoone?

Summary

How does Agilon Health compare to Sotera Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AGL vs. The Competition

Agilon Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Agilon Health (AGL) Competitors

AGL vs. HIMS, PACS, CAI, BLLN, and SHC

How does Agilon Health compare to Hims & Hers Health?

Do institutionals and insiders believe in AGL or HIMS?

Which has more volatility & risk, AGL or HIMS?

Do analysts recommend AGL or HIMS?

Does the media refer more to AGL or HIMS?

Is AGL or HIMS more profitable?

Which has higher earnings and valuation, AGL or HIMS?

Summary

How does Agilon Health compare to PACS Group?

Is PACS or AGL more profitable?

Which has higher valuation & earnings, PACS or AGL?

Do analysts recommend PACS or AGL?

Does the media favor PACS or AGL?

Summary

How does Agilon Health compare to Caris Life Sciences?

Does the media prefer CAI or AGL?

Is CAI or AGL more profitable?

Do analysts prefer CAI or AGL?

Which has higher earnings & valuation, CAI or AGL?

Summary

How does Agilon Health compare to Billiontoone?

Does the media favor AGL or BLLN?

Is AGL or BLLN more profitable?

Which has preferable earnings and valuation, AGL or BLLN?

Do analysts rate AGL or BLLN?

Summary

How does Agilon Health compare to Sotera Health?

Which has more volatility & risk, AGL or SHC?

Does the media favor AGL or SHC?

Do analysts recommend AGL or SHC?

Which has preferable valuation & earnings, AGL or SHC?

Is AGL or SHC more profitable?

Do insiders & institutionals believe in AGL or SHC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AGL vs. The Competition

Agilon Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools